Synapse - David Nemirovsky

Results (25)

Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications

Journal Article

Weigelt, B.; Marra, A.; Selenica, P.; Rios-Doria, E.; Momeni-Boroujeni, A.; Berger, M. F.; Arora, K.; Nemirovsky, D.; Iasonos, A.; Chakravarty, D.; more...
Cancer Discovery (2023)

Fulltext@MSK | Save

Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy

Meeting Abstract

Romesser, P. B.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Alvarez, J.; Omer, D. M. R.; Sarkar, R.; Verheij, F. S.; Reyngold, M.; Wu, A. J. C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma

Journal Article

Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
Blood Cancer Journal (2023)

Fulltext@MSK | Save

A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression

Meeting Abstract

Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
Blood (2022)

Fulltext@MSK | Save

Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) as induction therapy in newly diagnosed high-risk multiple myeloma

Meeting Abstract

Tan, C.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Patel, D.; Maclachlan, K. H.; Lahoud, O. B.; more...
Blood (2022)

Fulltext@MSK | Save